PE58799A1 - Inhibidores de la proteasa del vih - Google Patents

Inhibidores de la proteasa del vih

Info

Publication number
PE58799A1
PE58799A1 PE1998000171A PE00017198A PE58799A1 PE 58799 A1 PE58799 A1 PE 58799A1 PE 1998000171 A PE1998000171 A PE 1998000171A PE 00017198 A PE00017198 A PE 00017198A PE 58799 A1 PE58799 A1 PE 58799A1
Authority
PE
Peru
Prior art keywords
alkyl
optionally substituted
hiv protease
cycloalkyl
formula
Prior art date
Application number
PE1998000171A
Other languages
English (en)
Spanish (es)
Inventor
Kim F Albizati
Siegried Reich
Michael D Varney
Kanyin E Zhang
Takuo Kobayashi
Original Assignee
Agouron Pharma
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma, Japan Tobacco Inc filed Critical Agouron Pharma
Publication of PE58799A1 publication Critical patent/PE58799A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PE1998000171A 1997-03-13 1998-03-12 Inhibidores de la proteasa del vih PE58799A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81595197A 1997-03-13 1997-03-13

Publications (1)

Publication Number Publication Date
PE58799A1 true PE58799A1 (es) 1999-07-12

Family

ID=25219265

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000171A PE58799A1 (es) 1997-03-13 1998-03-12 Inhibidores de la proteasa del vih

Country Status (35)

Country Link
EP (1) EP0970055A2 (hu)
JP (1) JP2001516350A (hu)
KR (1) KR100511089B1 (hu)
CN (1) CN1179948C (hu)
AP (1) AP1358A (hu)
AR (1) AR012556A1 (hu)
AU (1) AU743078B2 (hu)
BG (1) BG63540B1 (hu)
BR (1) BR9808867A (hu)
CA (1) CA2284163A1 (hu)
CO (1) CO4940496A1 (hu)
CZ (1) CZ296647B6 (hu)
EA (1) EA002378B1 (hu)
EE (1) EE04114B1 (hu)
GE (1) GEP20022764B (hu)
HR (1) HRP980112A2 (hu)
HU (1) HUP0001380A3 (hu)
IL (2) IL131870A0 (hu)
IS (1) IS5176A (hu)
MX (1) MXPA99008395A (hu)
MY (1) MY117535A (hu)
NO (1) NO315555B1 (hu)
NZ (1) NZ337706A (hu)
OA (1) OA11196A (hu)
PA (1) PA8448801A1 (hu)
PE (1) PE58799A1 (hu)
PL (1) PL192786B1 (hu)
SA (1) SA98181116B1 (hu)
SK (1) SK283636B6 (hu)
SV (1) SV1998000038A (hu)
TR (1) TR199902508T2 (hu)
TW (1) TW200517112A (hu)
UA (1) UA57772C2 (hu)
WO (1) WO1998040357A2 (hu)
ZA (1) ZA982047B (hu)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
CO4940496A1 (es) 2000-07-24
HUP0001380A2 (hu) 2000-09-28
IS5176A (is) 1999-09-10
IL131870A0 (en) 2001-03-19
KR20000076236A (ko) 2000-12-26
EE9900416A (et) 2000-04-17
SV1998000038A (es) 1999-02-15
CA2284163A1 (en) 1998-09-17
CZ296647B6 (cs) 2006-05-17
EA002378B1 (ru) 2002-04-25
AU743078B2 (en) 2002-01-17
HUP0001380A3 (en) 2001-12-28
BG103727A (en) 2000-04-28
CZ319199A3 (cs) 2000-06-14
KR100511089B1 (ko) 2005-08-31
SA98181116B1 (ar) 2006-10-04
EA199900823A1 (ru) 2000-04-24
EP0970055A2 (en) 2000-01-12
PL192786B1 (pl) 2006-12-29
JP2001516350A (ja) 2001-09-25
NO994415L (no) 1999-11-10
MY117535A (en) 2004-07-31
NZ337706A (en) 2001-04-27
NO315555B1 (no) 2003-09-22
NO994415D0 (no) 1999-09-10
SK283636B6 (sk) 2003-11-04
TW200517112A (en) 2005-06-01
UA57772C2 (uk) 2003-07-15
BR9808867A (pt) 2000-07-11
WO1998040357A2 (en) 1998-09-17
AP1358A (en) 2004-12-03
EE04114B1 (et) 2003-08-15
AR012556A1 (es) 2000-11-08
PL335672A1 (en) 2000-05-08
AP9901648A0 (en) 1999-09-30
AU6457598A (en) 1998-09-29
CN1253548A (zh) 2000-05-17
IL131870A (en) 2006-04-10
BG63540B1 (bg) 2002-04-30
HRP980112A2 (en) 1998-12-31
WO1998040357A3 (en) 1998-11-26
SK122299A3 (en) 2000-05-16
OA11196A (en) 2003-05-21
TR199902508T2 (xx) 2000-02-21
ZA982047B (en) 1998-09-28
MXPA99008395A (es) 2003-08-12
CN1179948C (zh) 2004-12-15
PA8448801A1 (es) 2000-05-24
GEP20022764B (en) 2002-08-26

Similar Documents

Publication Publication Date Title
ES2258459T3 (es) Pirrolotriazinas inhibidoras de quinasas.
DK1106179T3 (da) Anvendelse af östrogenantagonister og östrogenagonister til hæmning af patologiske tilstande
DK1008592T3 (da) Cykliske amidderivater, som inhiberer cathepsin K
AR025386A1 (es) Moduladores de los receptores activados del proliferador de peroxisomas
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
ECSP941068A (es) Derivados de la cefalosporina
ES2177058T3 (es) Compuestos eter piperidinilaminometil trifluorometil ciclicos como antagonistas de la sustancia p.
DE69632365D1 (de) HIV-Protease Inhibitoren
CO4950567A1 (es) Inhibidores de proteasas dores de proteasas.
PT1064281E (pt) Derivados de distamicina benzo-heterociclicos processo para os preparar e a sua utilizacao como agentes antitumorais
ES2142773B1 (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
DE69323090T2 (de) 4-ALKOXY-2,6-DI-t-BUTYLPHENOLDERIVATE
AR246289A1 (es) Composicion inhibidora de polimerizacion.
MX9301045A (es) Procedimiento para preparar antagonistas receptores de fibrinogeno.
AR245699A1 (es) Compuestos derivados de n'-alquil-n,n'-diacilhidrazinas insecticidamente activos y composicion que los comprende.
MX9400194A (es) Materiales fototermograficos.
PE58799A1 (es) Inhibidores de la proteasa del vih
AR246120A1 (es) Derivados de n'-alquil-n,n'diacilhidracina insecticidamente activos y composicion que los comprende.
ATE196464T1 (de) Benzol-derivate, verwendbar für ischämische erkrankungen
CO5180536A1 (es) Inhibidores de proteasas catepsina
ES2171306T3 (es) Compuesto bajo la forma de isomero geometrico puro o de una mezcla de estos isomeros.
DK432086D0 (da) Fremgangsmaade til fremstilling af beta-lactamforbindelser eller saltederaf
ES2155655T3 (es) Compuestos de benzotiofeno, usos y formulaciones de los mismos.
ES2190781T3 (es) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano.
FI853685A0 (fi) Nya n-alk(en)yl-n-(o,o-disubstituerade -tiofosforyl)-n'n'-disubstituerade glycinamider, foerfarande foer framstaellning av dessa samt kvalstergifter, insektgifter och svampgifter vilka innehaoller dessa som aktiv bestaondsdel.

Legal Events

Date Code Title Description
FC Refusal